JUPITER LIFE LINE HOSPITALS LIMITED
₹ 695 - ₹ 735
06-Sep-2023 - 08-Sep-2023
₹ 14700.00

/ 20 Shares

JUPITER LIFE LINE HOSPITALS LIMITED

06-Sep-2023 - 08-Sep-2023

₹ 695 - ₹ 735

Price Band

₹ 14700.00

Minimum Investment

20

Bid Lot

11,824,163

Shares
  • Face Value - ₹ 10/- Per Share

  • Listing at NSE BSE

  • 206,922 Application Required in Retail for 1 Time.

  • Registrar : KFin Technologies Limited

IPO Details

Fresh Issue of Equity Shares aggregating upto ?615 Crore and Offer for Sale of upto 4,450,000 Equity Shares

Category % Shares/Amount
QIB 50% 5,912,080 Shares Rs. 434.54 Cr
HNI 1 5% 591,209 Shares Rs. 43.25 Cr @ 2111 Form 1x
HNI 2 10% 1,182,416 Shares Rs. 86.91 Cr @ 4223 Form 1x
Retail 35% 4,138,458 Shares Rs. 304.18 Cr @ 206923 Form 1x

ICICI Securities, Nuvama Wealth, JM Financial


Application Require for 1 Time

Retail (Upto 2 Lakh) HNI (2 Lakh to 10 Lakh) HNI (Above 10 Lakh)
206923 Form 1x 2111 Form 1x 4223 Form 1x

IPO Lot Size

Category Lots Shares Amount
Retail (Upto 2 Lakh) 1 20 ₹ 14,700
Retail (Upto 2 Lakh) 13 260 ₹ 191,100
S-HNI (2 Lakh to 10 Lakh) 14 280 ₹ 205,800
S-HNI (2 Lakh to 10 Lakh) 68 1360 ₹ 999,600
B-HNI (Above 10 Lakh) 69 1380 ₹ 1,014,300

IPO Timeline

  • Open Date

    06-Sep-2023
  • Close Date

    08-Sep-2023
  • Basis of Allotment Date

    13-Sep-2023
  • Initiation of Refunds

    14-Sep-2023
  • Credit Shares to Demat A/c

    15-Sep-2023
  • IPO Listing Date

    18-Sep-2023

Subscription as on
08-Sep-2023 17:01

Category Book Size Subscription No. of Times
QIB 2,364,832 ₹ 173.82 Cr. 444,494,800 ₹ 32670.37 Cr. 187.96x
HNI (<10 LAKH) 591,209 ₹ 43.45 Cr. 15,785,100 ₹ 1160.20 Cr. 26.70x
HNI2 (>10 LAKH) 1,182,416 ₹ 86.91 Cr. 48,057,860 ₹ 3532.25 Cr. 40.64x
RETAIL 4,138,458 ₹ 304.18 Cr. 33,068,100 ₹ 2430.51 Cr. 7.99x
Total 8,276,915 541,405,860 65.41x
Category Book Size Subscription No. of Times
QIB 2,364,832 ₹ 173.82 Cr. 444,494,800 ₹ 32670.37 Cr. 187.96x
HNI (<10 LAKH) 591,209 ₹ 43.45 Cr. 15,785,100 ₹ 1160.20 Cr. 26.70x
HNI2 (>10 LAKH) 1,182,416 ₹ 86.91 Cr. 48,057,860 ₹ 3532.25 Cr. 40.64x
RETAIL 4,138,458 ₹ 304.18 Cr. 33,068,100 ₹ 2430.51 Cr. 7.99x
Total 8,276,915 541,405,860 65.41x

*Excluding Anchor

Total No. of Application Approx : ~1427750 (6.90 Appwise)

Disclaimer: The above-mentioned information / data are sourced from the websites of National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) and are subject to change on real time basis. For updated information / data you can visit their respective website. The information / data provided herein above are for information purpose only and provided "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. We do not guarantee or warrant the accuracy, adequacy or completeness of the information received through the said websites. “We” hold not responsibility of any kind as regard to any discrepancies, errors, omissions, losses or damages. “We” including its affiliates and any of its officers, directors, personnel and employees, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of information / data received through the said websites. The recipient alone shall be fully responsible / are liable for any decision taken on the basis of such information / data. All recipients should before acting upon the said information make their own investigation, seek appropriate professional advice.

About Company

  • Jupiter Life Line Hospitals Limited (“JLHL”) was incorporated on November 18, 2002. JLHL is among the key multi-specialty tertiary and quaternary healthcare providers in the Mumbai Metropolitan Area (MMR) and western region of India with a total bed capacity of 1,194 hospital beds across 3 hospitals as of March 31, 2023. 
  • They have been operating for over 15 years as a corporate quaternary care healthcare service provider in densely populated micro markets in the western regions of India and currently operate 3 hospitals under the “Jupiter” brand in Thane, Pune and Indore, with an operational bed capacity (i.e. census and non-census beds) of 950 beds and 1,306 doctors including specialists, physicians and surgeons, as of March 31, 2023. The current operational bed capacity is 961 beds. 

  • They have equipped their hospitals with over 30 specialties, as of March 31, 2023, including key specialties of organ transplant, oncology, orthopaedics, cardiology, paediatrics, neurology, and neurosurgery as well as certain specialised quaternary services and precision-based treatments such as brachytherapy, radiotherapy, robotic knee replacement and robotic neuro rehabilitation.  

  • JLHL commenced operations in 2007 with their hospital in Thane, Maharashtra and subsequently scaled their operations by setting up a hospital in Pune, Maharashtra in 2017 and acquiring a hospital in Indore, Madhya Pradesh in 2020 

  • Each of their hospitals at Thane, Pune and Indore has been certified by the National Accreditation Board for Hospitals & Healthcare Providers (“NABH”) and has been accredited in the field of medical testing by the National Accreditation Board for Testing and Calibration Laboratories (“NABL”). 

  • Their hospitals function on an ‘all-hub-no-spoke’ model with each hospital being a full-service hospital, operating independently and serving the healthcare needs of patients, right from diagnostics to surgery and rehabilitation. Their Thane and Pune hospitals are “greenfield” projects, and all 3 of their hospitals are located on land owned by them on a freehold basis. 

  • They are also currently in the process of developing a multi-specialty hospital in Dombivli, Maharashtra, which is designed to accommodate over 500 beds and has recently commenced construction in April 2023. 

Read More

Strengths

  • Key multi-specialty tertiary and quaternary healthcare provider with a track record of over 15 years, strong brand recognition and clinical expertise; 
  • All-hub-no-spoke’ model with focus on quality patient care supported by modern infrastructure and technological capabilities;
  • Ability to attract and retain skilled and experienced healthcare professionals;
  • Track-record of operational and financial performance with a diversified revenue mix;
  • Experienced and qualified professional management team with a focus on environmental, social and governance (“ESG”) initiatives;

Company Promoters

Dr Ajay Thakker is the Promoter, Chairman and Managing Director of the company. Dr Ankit Thakker is the Promoter, Executive Director, and Chief Executive Officer of the company. Dr Bhaskar Shah is a Non-Executive Director of the company. Vadapatra Raghavan is a Non-Executive Director of the Company. Dr Darshan Vora is an Independent Director of the company. Dr Jasmin Patel is an Independent Director of the Board of the company. Satish Utekar is an Independent Director of the company. Urm

Company Financials

Jupiter Life Line Hospitals IPO Financial Information (Restated Consolidated)
Period Ended 31 Mar 2021 31 Mar 2022 31 Mar 2023
Assets 788.91 908.70 985.53
Revenue 490.27 737.14 902.96
Profit After Tax -2.30 51.13 72.91
Net Worth 246.44 288.43 363.91
Reserves and Surplus      
Total Borrowing 425.52 495.25 468.63

Amount in ? Crore

Objects of the Issue

  1. Repayment/pre-payment, in full or part, of borrowings availed from banks by the company and Material Subsidiary; and
  2. General corporate purposes.

How to Apply

Apply for IPO in few simple steps.

  • Step 01 :

    Once you create your account, Login to Us.

  • Step 02 :

    Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.

  • Step 03 :

    Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).

  • Step 04 :

    Enter your UPI ID and you will receive mandate on your UPI App.

  • Step 05 :

    Once you accept the mandate, Application is submitted successful.

  • Applying for an IPO is easier than ever with Us, in just a few clicks your application is processed. You can bid for any IPO through Us, the bidding process is simple and hassle free. Every company has a lot size decided & you can buy in multiples of the decided lot.
  • If lot size is 15, then you have to bid for multiples of 15 share like 30,45,60 and so on.
  • The maximum subscription amount for retail investors is 2 lakh.
  • Any bid can be at a desired price or cut off price given by the company.

  • Enter the number of shares you wish to buy, as per the lot size.
  • You can apply at the cut off price set by the company or bid for a desired amount within the price band.
  • Maximum three bids will be accepted.
  • You then need to enter the UPI ID on IPO application form.

  • You will immediately get a fund blocked request on your UPI for the submitted IPO application.
  • The funds will be blocked in your bank account until allotment when it is debited.
  • The limit for IPO application is Rs 2 lakh per transaction on UPI.
  • On allotment of the shares, the money will be automatically debited.
  • If the share aren’t allotted the blocked funds will reflect back into your account.

Frequently Asked Questions

Check Allotment